nimesulide and 15-deoxyprostaglandin j2

nimesulide has been researched along with 15-deoxyprostaglandin j2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, Y; Hisatome, I; Kishina, M; Koda, M; Tanaka, K; Tsujimoto, S; Yamamoto, Y; Yoshida, A	1

Other Studies

1 other study(ies) available for nimesulide and 15-deoxyprostaglandin j2

Article	Year
Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ. International journal of molecular medicine, 2016, Volume: 38, Issue:3 Topics: Animals; Chemokine CCL2; Collagen Type I; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diet, High-Fat; Gene Expression; Glucose; Immunohistochemistry; Insulin; Insulin Resistance; Kupffer Cells; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1; Triglycerides	2016

Article

Year

Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.

International journal of molecular medicine, 2016, Volume: 38, Issue:3

Topics: Animals; Chemokine CCL2; Collagen Type I; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diet, High-Fat; Gene Expression; Glucose; Immunohistochemistry; Insulin; Insulin Resistance; Kupffer Cells; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1; Triglycerides

2016